10. EVALUATION OF THE EFFICACY AND SAFETY FOR THE COMBINATION USE OF ORAL AND TOPICAL TRANEXAMIC ACID IN THE TREATMENT OF MELASMA AT HO CHI MINH CITY DERMATOLOGY HOSPITAL
Nội dung chính của bài viết
Tóm tắt
Objective: To evaluate the effectiveness and safety of oral and topical tranexamic acid in the treatment of melasma.
Subjects and methods: A descriptive study of a series of cases with longitudinal follow-up was conducted on 28 female patients with melasma at the Ho Chi Minh City Dermatology Hospital from April 2024 to August 2024.
Results: The study subjects had an average age of 47.46 ± 8.23 (34 - 63) years old, 78.57% had a family history of melasma. The assessment of melasma improvement according to the PGA scale showed that 100% of patients had melasma improvement of over 25% (50.00% had good improvement of 51-75%). MASI index had a significant improvement after treatment compared to before treatment with statistical significance with p<0.001. All patients were satisfied after treatment with 57.14% of patients being very satisfied, 92.86% having no side effects.
Conclusion: Oral and topical tranexamic acid is an effective and safe method for treating melasma.
Chi tiết bài viết
Từ khóa
tranexamic acid, oral and topical, melasma
Tài liệu tham khảo
[2] Desai, S., et al., Optimizing Melasma Management With Topical Tranexamic Acid: An Expert Consensus. Journal of drugs in dermatology: JDD, 2023. 22(4): p. 386-392.
[3] Sheu, S.L., Treatment of melasma using tranexamic acid: what's known and what's next. Cutis, 2018. 101(2): p. E7-E8.
[4] Taraz, M., S. Niknam, and A.H. Ehsani, Tranexamic acid in treatment of melasma: A comprehensive review of clinical studies. Dermatologic therapy, 2017. 30(3): p. e12465.
[5] Le Thai Van Thanh, T.Q.H., Le Vi Anh, Tran Ngoc Khanh Nam, Thach Van Toan, Tran Hanh Vy, Nguyen Thi Cam Phan, Quynh Nhu. Effectiveness of 5% cysteamine hydrochloride topical application in the treatment of melasma. Vietnamese Medical Journal. 2023. 531(1).
[6] Luu Truc Linh, H.V.B., Ngo Minh Vinh, Nguyen Hong Ha. Clinical characteristics and some related factors in melasma patients at the University of Medicine and Pharmacy Hospital Can Tho and FOB International Aesthetic Dermatology Research Institute in 2022-2023. Vietnamese Medical Journal. 2023. 529(1B).
[7] Tan, A.W.M., et al., Oral tranexamic acid lightens refractory melasma. Australasian Journal of Dermatology, 2017. 58(3): p. e105-e108.
[8] Na, J., et al., Effect of tranexamic acid on melasma: a clinical trial with histological evaluation. Journal of the European Academy of Dermatology and Venereology, 2013. 27(8): p. 1035-1039.
[9] Lee, Y.B., et al., Combination treatment of low-fluence Q-switched Nd: YAG laser and oral tranexamic acid for post-inflammatory hyperpigmentation due to allergic contact dermatitis to henna hair dye. Journal of Cosmetic and Laser Therapy, 2016. 18(2): p. 95-97.
[10] Perper, M., et al., Tranexamic acid in the treatment of melasma: a review of the literature. American journal of clinical dermatology, 2017. 18: p. 373-381.